Medizone International, Inc. (OTC Bulletin Board: MZEI) announces that following several months of research, AsepticSure(TM) can now achieve a level of bacterial decontamination heretofore unseen in open space settings using conventional means.
Dr Michael E. Shannon, Director of Medical Affairs, Medizone International stated, "Our research team has pressed hard over the last few months to systematically evaluate various decontamination options involving numerous technological approaches in combination, and to our surprise, we have managed reliably and predictably to break through the 6 log barrier with MRSA. This unexpected development will significantly expand the utility for AsepticSure(TM), since by definition, any bacterial reduction beyond 6 logs (99.9999%) is considered STERILIZATION. This unique combination of technologies and protocols will now be tested on C difficile, E coli, Pseudomonas aeruginous, and VRE with the expectation that AsepticSure(TM) will achieve the same degree of incremental improvement over the 4 to 5 log reductions we have already demonstrated with those pathogens in earlier trials."
Medizone International is preparing a second patent filing to cover these developments while construction and instrumentation of an expanded laboratory setting at the company's Innovation Park, Queens University laboratory continues in preparation for full room scale-up testing of its equipment to commence in December.
Can soda taxes fight obesity? New research adds to the debate